about
The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patientsHydroxyurea and Zileuton Differentially Modulate Cell Proliferation and Interleukin-2 Secretion by Murine Spleen Cells: Possible Implication on the Immune Function and Risk of Pain Crisis in Patients with Sickle Cell DiseaseIntestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease.Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia.Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.Effect of Hereditary Hemochromatosis Gene H63D and C282Y Mutations on Iron Overload in Sickle Cell Disease Patients.An unfortunate case of acquired hemochromatosis: a case report review of the clinical presentation, diagnosis, management, and prognosis.The role of nutrition in the pathophysiology and management of sickle cell disease among children: A review of literature.Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia.Acute and chronic hepatobiliary manifestations of sickle cell disease: A review.Hepatic Iron Quantification on 3 Tesla (3 T) Magnetic Resonance (MR): Technical Challenges and Solutions.Effect of iron overload on renal functions and oxidative stress in beta thalassemia patientsCrosstalk between Erythropoiesis and Iron Metabolism.Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals.Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload.Possible Risk Factors for Severe Anemia in Hospitalized Sickle Cell Patients at Muhimbili National Hospital, Tanzania: Protocol for a Cross-Sectional Study.
P2860
Q33955451-2A0590BA-2BEE-4646-A71F-3211024BA35EQ36058141-F01081E7-CDB6-4930-9049-DA2E76FD1B0AQ36092963-E38E17CD-9EE3-499C-B075-4ED61C362618Q36195042-2719622E-A6AA-4057-A548-B6DC9F41F982Q37458594-8BA2A948-09C7-4433-B672-11E63B3B6C4DQ37548261-72B50625-E0F8-42C5-BB22-BF82C41CCDCBQ39043944-F1F86257-C4B6-4CE3-856B-5659D67D76A3Q39420586-21052426-A11C-44D9-911D-8CBE1A577AEAQ40829777-D29A7ED0-FC53-4AEA-99E3-2A8B4FD9A01CQ41449932-BB075E3B-3D94-4575-A4D4-8D00B389A99BQ41814500-447630B8-778B-4F7E-87C4-7BD72435458FQ41842325-2051AA8B-D794-43AC-A2F4-CA03B91D0DE1Q42182715-44971917-9286-41F6-BC2F-EC2CA1E45192Q42203065-3539C225-3646-4EC5-BFC2-9EBEE4660DA4Q50212098-0E29D06C-C59C-4130-BE2C-A23B608AC66DQ53701676-51F93024-BAD6-4BE2-B49D-4FA00C03EFA4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Iron overload in sickle cell disease.
@ast
Iron overload in sickle cell disease.
@en
type
label
Iron overload in sickle cell disease.
@ast
Iron overload in sickle cell disease.
@en
prefLabel
Iron overload in sickle cell disease.
@ast
Iron overload in sickle cell disease.
@en
P2860
P356
P1476
Iron overload in sickle cell disease
@en
P2093
Deepa Manwani
Jane A Little
P2860
P304
P356
10.1155/2010/272940
P577
2010-05-17T00:00:00Z